This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA291821; GEO: GSE71691 |
| Type | Umbrella project |
| Publications | Barabé F et al., "Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target.", Leukemia, 2017 May;31(5):1166-1176 |
| Submission | Registration date: 4-Aug-2015
High-throughput sequencing, IRIC |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 55 |
| Publications |
| PubMed | 1 |
| Other datasets |
| BioSample | 55 |
| GEO DataSets | 8 |
Integrative epigenomic analysis in MLL-AF9 acute myeloid leukemia (AML) and B-acute lymphoblastic leukemia (B-ALL) encompasses the following 7 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA289498 | Homo sapiens | Integrative epigenomic analysis in MLL-AF9 acute myeloid leukemia (AML) and B-acute lymphoblastic leukemia (B-ALL) (High-throughput sequencing,...) |
|
| Transcriptome or Gene expression | 6 |
BioProject
accession | Organism | Title |
|---|
| PRJNA291824 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets [RNA-Seq_normal] (High-throughput sequencing,...) | | PRJNA291825 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets [RNA-Seq_AML] (High-throughput sequencing,...) | | PRJNA292133 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) (High-throughput sequencing,...) | | PRJNA292311 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) (High-throughput sequencing,...) | | PRJNA292831 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq shRNA) (High-throughput sequencing,...) |
List all 6 'Transcriptome or Gene expression' projects...BioProject
accession | Organism | Title |
|---|
| PRJNA291824 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets [RNA-Seq_normal] (High-throughput sequencing,...) | | PRJNA291825 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets [RNA-Seq_AML] (High-throughput sequencing,...) | | PRJNA292133 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) (High-throughput sequencing,...) | | PRJNA292311 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) (High-throughput sequencing,...) | | PRJNA292831 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq shRNA) (High-throughput sequencing,...) | | PRJNA292885 | Homo sapiens | Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (Leukemia Cell Bank) (High-throughput sequencing,...) |
Less... |